EXEL vs SCNI
Exelixis, Inc. - Common Stock · Scinai Immunotherapeutics Ltd. - American Depositary Shares
Relative return (rebased to 100)
Key stats
| Metric | EXEL | SCNI |
|---|---|---|
| Price | $68.29 | $1.47 |
| Market Cap | $16.66B | $20.38B |
| P/E | 21.29 | — |
| P/B | 9.09 | 2515.37 |
| P/S | 7.18 | 15546.96 |
| ROE | 42.7% | -102.5% |
| Net Margin | 33.7% | -633.6% |
| Gross Margin | — | -202.3% |
| Revenue Growth | 7.0% | 99.2% |
| Dividend Yield | — | — |
| EPS | $3.21 | -$0.00 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.